Randomized phase 2 study to evaluate the efficacy and safety of silevertinib in combination with temozolomide in newly diagnosed patients with EGFRvIII-positive IDHwt MGMT unmethylated glioblastoma

temozolomide - Generic mfg.

silevertinib (BDTX-1535) - Black Diamond Therap

https://virtual.oxfordabstracts.com/event/76734/session/223371

Patrick Wen; Fabio Iwamoto; Rupesh Kotecha; Robert Aiken; Joseph Beck; Milan Chheda; Jan Drappatz; Jeffery Edenfield; Sylvia Kurz; Peter Pan; Jeremy Rudnick; Shannon Matheny; Sergey Yurasov; Vinay Puduvalli

Sep 9, 2026